RESUMO
Until very recently addiction-research was limited by existing tools and strategies that were inadequate for studying the inherent complexity at each of the different phenomenological levels. However, powerful new tools (e.g., optogenetics and designer drug receptors) and high throughput protocols are starting to give researchers the potential to systematically interrogate "all" genes, epigenetic marks, and neuronal circuits. These advances, combined with imaging technologies (both for preclinical and clinical studies) and a paradigm shift toward open access have spurred an unlimited growth of datasets transforming the way we investigate the neurobiology of substance use disorders (SUD) and the factors that modulate risk and resilience. This article is part of a Special Issue entitled 'NIDA 40th Anniversary Issue'.
Assuntos
Pesquisa Biomédica , Neurobiologia , Transtornos Relacionados ao Uso de Substâncias , Animais , Humanos , Optogenética , Transtornos Relacionados ao Uso de Substâncias/genética , Transtornos Relacionados ao Uso de Substâncias/fisiopatologia , Transtornos Relacionados ao Uso de Substâncias/terapiaRESUMO
Drug addiction and obesity appear to share several properties. Both can be defined as disorders in which the saliency of a specific type of reward (food or drug) becomes exaggerated relative to, and at the expense of others rewards. Both drugs and food have powerful reinforcing effects, which are in part mediated by abrupt dopamine increases in the brain reward centres. The abrupt dopamine increases, in vulnerable individuals, can override the brain's homeostatic control mechanisms. These parallels have generated interest in understanding the shared vulnerabilities between addiction and obesity. Predictably, they also engendered a heated debate. Specifically, brain imaging studies are beginning to uncover common features between these two conditions and delineate some of the overlapping brain circuits whose dysfunctions may underlie the observed deficits. The combined results suggest that both obese and drug-addicted individuals suffer from impairments in dopaminergic pathways that regulate neuronal systems associated not only with reward sensitivity and incentive motivation, but also with conditioning, self-control, stress reactivity and interoceptive awareness. In parallel, studies are also delineating differences between them that centre on the key role that peripheral signals involved with homeostatic control exert on food intake. Here, we focus on the shared neurobiological substrates of obesity and addiction.
Assuntos
Comportamento Aditivo , Obesidade/epidemiologia , Obesidade/metabolismo , Recompensa , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Encéfalo/metabolismo , Comorbidade , Dopamina/metabolismo , Ingestão de Alimentos/fisiologia , Ingestão de Alimentos/psicologia , Humanos , Modelos Biológicos , Vias Neurais , Obesidade/psicologia , Transtornos Relacionados ao Uso de Substâncias/metabolismo , Transtornos Relacionados ao Uso de Substâncias/psicologiaRESUMO
Both drug addiction and obesity can be defined as disorders in which the saliency value of one type of reward (drugs and food, respectively) becomes abnormally enhanced relative to, and at the expense of others. This model is consistent with the fact that both drugs and food have powerful reinforcing effects-partly mediated by dopamine increases in the limbic system-that, under certain circumstances or in vulnerable individuals, could overwhelm the brain's homeostatic control mechanisms. Such parallels have generated significant interest in understanding the shared vulnerabilities and trajectories between addiction and obesity. Now, brain imaging discoveries have started to uncover common features between these two conditions and to delineate some of the overlapping brain circuits whose dysfunctions may explain stereotypic and related behavioral deficits in human subjects. These results suggest that both obese and drug-addicted individuals suffer from impairments in dopaminergic pathways that regulate neuronal systems associated not only with reward sensitivity and incentive motivation, but also with conditioning (memory/learning), impulse control (behavioural inhibition), stress reactivity, and interoceptive awareness. Here, we integrate findings predominantly derived from positron emission tomography that shed light on the role of dopamine in drug addiction and in obesity, and propose an updated working model to help identify treatment strategies that may benefit both of these conditions.
Assuntos
Encéfalo/fisiopatologia , Alimentos , Obesidade/patologia , Recompensa , Transtornos Relacionados ao Uso de Substâncias/patologia , Animais , Encéfalo/diagnóstico por imagem , Encéfalo/metabolismo , Dopamina/metabolismo , Humanos , Vias Neurais/metabolismo , Vias Neurais/patologia , Obesidade/diagnóstico por imagem , Tomografia por Emissão de Pósitrons , Transtornos Relacionados ao Uso de Substâncias/diagnóstico por imagemRESUMO
Dopamine is involved in drug reinforcement but its role in addiction is less clear. Here we describe PET imaging studies that investigate dopamine's involvement in drug abuse in the human brain. In humans the reinforcing effects of drugs are associated with large and fast increases in extracellular dopamine, which mimic those induced by physiological dopamine cell firing but are more intense and protracted. Since dopamine cells fire in response to salient stimuli, supraphysiological activation by drugs is experienced as highly salient (driving attention, arousal, conditioned learning and motivation) and with repeated drug use may raise the thresholds required for dopamine cell activation and signaling. Indeed, imaging studies show that drug abusers have marked decreases in dopamine D2 receptors and in dopamine release. This decrease in dopamine function is associated with reduced regional activity in orbitofrontal cortex (involved in salience attribution; its disruption results in compulsive behaviors), cingulate gyrus (involved in inhibitory control; its disruption results in impulsivity) and dorsolateral prefrontal cortex (involved in executive function; its disruption results in impaired regulation of intentional actions). In parallel, conditioning triggered by drugs leads to enhanced dopamine signaling when exposed to conditioned cues, which then drives the motivation to procure the drug in part by activation of prefrontal and striatal regions. These findings implicate deficits in dopamine activity-inked with prefrontal and striatal deregulation-in the loss of control and compulsive drug intake that results when the addicted person takes the drugs or is exposed to conditioned cues. The decreased dopamine function in addicted individuals also reduces their sensitivity to natural reinforcers. Therapeutic interventions aimed at restoring brain dopaminergic tone and activity of cortical projection regions could improve prefrontal function, enhance inhibitory control and interfere with impulsivity and compulsive drug administration while helping to motivate the addicted person to engage in non-drug related behaviors.
Assuntos
Diagnóstico por Imagem , Dopamina/metabolismo , Transtornos Relacionados ao Uso de Substâncias/metabolismo , Transtornos Relacionados ao Uso de Substâncias/patologia , Animais , Encéfalo/metabolismo , Encéfalo/fisiopatologia , Humanos , Transtornos Relacionados ao Uso de Substâncias/psicologiaRESUMO
The pineal gland is a major output of the endogenous vertebrate circadian clock, with melatonin serving as the output signal. In many species, elevated nocturnal melatonin production is associated with changes in pineal gene expression. In the current study, cDNA array analysis was used in an attempt to identify additional genes that exhibit day/night differential expression in the rat pineal gland. This revealed 38 candidate genes, including Id-1 (inhibitor of DNA binding and differentiation). Id-1 encodes a helix-loop-helix (HLH) protein that lacks a basic DNA binding domain and could affect pineal physiology via a dominant negative trans-acting regulatory activity. For this reason Id-1 was selected for further analysis. Id-1 was expressed in a major population of pineal cells and the Id-1 protein was associated with a nuclear complex. The levels of Id-1 mRNA and protein exhibit approximately six-fold day/night rhythms. In contrast, the related genes Id-2 and Id-3 do not exhibit marked day/night differences in pineal expression. Rhythmic Id-1 expression is primarily limited to a C-terminally extended splice variant of Id-1, which would restrict the functional output of the rhythm to protein binding partners of this isoform of Id-1. Our findings add to the body of evidence indicating that transcriptional regulators play a role in neuroendocrine rhythms, and extend this by introducing the concept of a dominant negative HLH involvement. The rhythm in Id-1 in the pineal gland provides an experimental opportunity to identify Id-1-binding partners which may also be involved in Id-1 activity in other functional contexts.
Assuntos
Ritmo Circadiano/fisiologia , Proteínas de Ligação a DNA/genética , Glândula Pineal/fisiologia , Proteínas Repressoras , Fatores de Transcrição/genética , Animais , Expressão Gênica/fisiologia , Sequências Hélice-Alça-Hélice/genética , Proteína 1 Inibidora de Diferenciação , Masculino , Melatonina/metabolismo , Análise de Sequência com Séries de Oligonucleotídeos , RNA Mensageiro/análise , Ratos , Ratos Sprague-DawleyRESUMO
Fos-related antigen 2 (Fra-2) is a member of the Fos family of immediate-early genes, most of which are rapidly induced by second messengers. All members of this family act by binding to AP-1 sites as heterodimeric complexes with other proteins. However, each appears to have a distinct role. The role and biology of Fra-2 are less well understood than those of its relatives c-Fos, Fra-1, and FosB; moreover, Fra-2 target genes remain largely unknown, as does the basis of its selective effects on transcriptional activity. To pursue these issues, we created a transgenic rat line (NATDNF2) in which a dominant negative fra-2 (DNF2) gene is strongly expressed in the pineal gland; tissue selectivity was achieved by putting the DNF2 gene under the control of the rat arylalkylamine N-acetyltransferase (AANAT) regulatory region, which targets gene expression to a very restricted set of tissues (pineal gland >> retina). Expression of AANAT is normally turned on after the onset of darkness in the rat; as a result, pineal DNF2 expression occurs only at night. This was associated with marked suppression of the nocturnal increase in fra-2 mRNA and protein levels, indicating that DNF2 expression inhibits downstream effects of Fra-2, including the maintenance of high levels of fra-2 gene expression. Analysis of 1,190 genes in the NATDNF2 pineal gland, including the AANAT gene, identified two whose expression is strongly linked to fra-2 expression: the genes encoding type II iodothyronine deiodinase and nectadrin (CD24).
Assuntos
Proteínas de Ligação a DNA/metabolismo , Regulação da Expressão Gênica , Proteínas Imediatamente Precoces/metabolismo , Fatores de Transcrição/metabolismo , Células 3T3 , Sequência de Aminoácidos , Animais , Animais Geneticamente Modificados , Arilamina N-Acetiltransferase/genética , Proteínas de Ligação a DNA/genética , Antígeno 2 Relacionado a Fos , Expressão Gênica , Proteínas Imediatamente Precoces/genética , Melatonina/biossíntese , Melatonina/genética , Camundongos , Dados de Sequência Molecular , Mutagênese , Análise de Sequência com Séries de Oligonucleotídeos , Fenótipo , Glândula Pineal/metabolismo , Regiões Promotoras Genéticas , Coelhos , Ratos , Distribuição Tecidual , Fatores de Transcrição/genética , Células Tumorais CultivadasRESUMO
In spite of its apparent weakness as a clock model, the budding yeast has spawned a technique that has revolutionized our ability to study specific protein-protein interactions like those at the core of the molecular timekeeping mechanisms. Here, the author will summarize the evolution, power, and limitations of this technique and highlight its potential and actual contributions to the field of chronobiology.
Assuntos
Leveduras/crescimento & desenvolvimento , Animais , Ritmo Circadiano , Humanos , Hibridização Genética , PeriodicidadeRESUMO
The rat arylalkylamine N-acetyltransferase (AA-NAT) gene encodes the key enzyme whose rhythmic expression drives the nocturnal production of melatonin. It is of interest that this enzyme is expressed virtually exclusively in two phylogenetically related tissues: retinal photoreceptors, which harbor an endogenous clock, and pinealocytes which, in higher vertebrates, function strictly in response to the master oscillator in the suprachiasmatic nucleus (SCN). While much is known about AA-NAT transcriptional regulation in the rat pineal gland (a slave oscillator), a full understanding of the mechanisms controlling AA-NAT gene expression in the retina by the clock is lacking. In the present study we have identified a functional E box in the first intron of the rat AA-NAT gene which is capable of mediating transcriptional upregulation via the action of a bMAL/CLOCK heterodimer. This is the first report to characterize the AA-NAT gene as a possible direct transcriptional target of the biological clock loop in a master oscillator.
Assuntos
Arilamina N-Acetiltransferase/genética , Relógios Biológicos , Ritmo Circadiano/genética , Regulação Enzimológica da Expressão Gênica , Glândula Pineal/fisiologia , Retina/fisiologia , Transcrição Gênica , Animais , Sequência de Bases , Células Cultivadas , Íntrons , Dados de Sequência Molecular , Oscilometria , Glândula Pineal/enzimologia , Regiões Promotoras Genéticas , Ratos , Proteínas Recombinantes/biossíntese , Retina/enzimologia , Núcleo Supraquiasmático/fisiologia , TransfecçãoRESUMO
Extensive studies have established that light regulates c-fos gene expression in the suprachiasmatic nucleus, the site of an endogenous circadian clock, but relatively little is known about the expression of genes structurally related to c-fos, including fra-1, fra-2 and fosB. We analysed the photic and temporal regulation of these genes at the messenger RNA and immunoreactive protein levels in rat suprachiasmatic nucleus, and we found different expression patterns after photic stimulation and depending on location in the ventrolateral or dorsomedial subdivisions. In the ventrolateral suprachiasmatic nucleus, c-fos, fra-2 and fosB expression was stimulated after a subjective-night (but not subjective-day) light pulse. Expression of the fra-2 gene was prolonged following photic stimulation, with elevated messenger RNA and protein levels that appeared unchanged for at least a few hours beyond the c-fos peak. Unlike c-fos and fra-2, the fosB gene appeared to be expressed constitutively in the ventrolateral suprachiasmatic nucleus throughout the circadian cycle; immunohistochemical analysis suggested that delta FosB was the protein product accounting for this constitutive expression, while FosB was induced by the subjective-night light pulse. In the dorsomedial suprachiasmatic nucleus, c-fos and fra-2 expression exhibited an endogenous circadian rhythm, with higher levels during the early subjective day, although the relative abundance was much lower than that measured after light pulses in the ventrolateral suprachiasmatic nucleus. Double-label immunohistochemistry suggested that some of the dorsomedial cells responsible for the circadian expression of c-Fos also synthesized arginine vasopressin. No evidence of suprachiasmatic nucleus fra-1 expression was found. In summary, fos family genes exhibit differences in their specific expression patterns in the suprachiasmatic nucleus, including their photic and circadian regulation in separate cell populations in the ventrolateral and dorsomedial subdivisions. The data, in combination with our previous results [Takeuchi J. et al. (1993) Neuron 11, 825-836], suggest that activator protein-1 binding sites on ventrolateral suprachiasmatic nucleus target genes are constitutively occupied by DeltaFosB/JunD complexes, and that c-Fos, Fra-2, FosB and JunB compete for binding after photic stimulation. The differential regulation of fos family genes in the ventrolateral and dorsomedial suprachiasmatic nucleus suggests that their circadian function(s) and downstream target(s) are likely to be cell specific.
Assuntos
Ritmo Circadiano/genética , Proteínas Proto-Oncogênicas c-fos/genética , Núcleo Supraquiasmático/fisiologia , Animais , Arginina Vasopressina/genética , Regulação da Expressão Gênica/fisiologia , Genes Precoces/fisiologia , Masculino , Estimulação Luminosa , RNA Mensageiro/análise , Ratos , Ratos Sprague-Dawley , Núcleo Supraquiasmático/químicaRESUMO
The bacterial gene chloramphenicol acetyltransferase (CAT) is a widely used reporter in both in-vitro and in-vivo studies of genetic regulation. We have recently generated novel rat transgenic lines carrying an arylalkylamine N-acetyltransferase (AA-NAT) promoter-reporter construct in which CAT (with associated SV40 small-t antigen sequence) is the reporter. In addition to the predicted transgene transcript (1.9 kb), we identified an abundant 1.5 kb transcript which derives from an alternative splicing event that utilises a cryptic splice donor site located within the CAT gene. The native CAT open reading frame (ORF) is lost in the 1.5 kb transcript, and a western analysis has shown that protein deriving from an aberrant open reading frame is not expressed at detectable levels.
Assuntos
Processamento Alternativo , Antígenos Transformantes de Poliomavirus/genética , Cloranfenicol O-Acetiltransferase/genética , Transgenes , Animais , Animais Geneticamente Modificados , Antígenos Transformantes de Poliomavirus/metabolismo , Arilamina N-Acetiltransferase/genética , Arilamina N-Acetiltransferase/metabolismo , Sequência de Bases , Northern Blotting , Western Blotting , Cloranfenicol O-Acetiltransferase/metabolismo , Feminino , Genes Reporter , Microinjeções , Dados de Sequência Molecular , Fases de Leitura Aberta , Ratos , Sequências Reguladoras de Ácido Nucleico , Reação em Cadeia da Polimerase Via Transcriptase Reversa , ZigotoRESUMO
The arylalkylamine N-acetyltransferase (AA-NAT) gene is strongly expressed in the rat primarily in the pineal gland; low levels of expression are also found in the retina. AA-NAT catalyzes the key regulatory step controlling rhythmic melatonin output: the acetylation of serotonin. In the rat, the AA-NAT gene is expressed at night. This is controlled partly by cyclic AMP (cAMP) acting through a composite cAMP-responsive element-CCAAT site located upstream of the transcription start point. In the present study, we have extended our previous in vitro findings and found that additional elements in the 5' flanking region and first intron play an important role in the regulation of the AA-NAT gene. This led us to test the influence of an AA-NAT 5' flanking segment on the expression of the bacterial chloramphenicol acetyltransferase gene in a rat transgenic model. The results of this study clearly demonstrate that the segment of the AA-NAT gene that encompasses the minimal promoter and the first intron is able to confer the highly specific pineal/retinal and time-of-day patterns of AA-NAT gene expression. This advance also provides a tool that selectively targets genetic expression to pinealocytes and retinal photoreceptors, providing new experimental opportunities to probe gene expression in these tissues.
Assuntos
Arilamina N-Acetiltransferase/genética , Ritmo Circadiano , Regulação Enzimológica da Expressão Gênica , Glândula Pineal/enzimologia , Regiões Promotoras Genéticas , Retina/enzimologia , Animais , Animais Geneticamente Modificados , Sequência de Bases , Células Cultivadas , Cloranfenicol O-Acetiltransferase/biossíntese , Cloranfenicol O-Acetiltransferase/genética , Escuridão , Íntrons , Luz , Dados de Sequência Molecular , Ratos , Proteínas Recombinantes/biossíntese , Vírus 40 dos Símios/genética , Transcrição GênicaRESUMO
The daily rhythm in the activity of arylalkylamine N-acetyltransferase (AA-NAT) controls the rhythm in melatonin synthesis in the pineal gland. In the rat, transcriptional regulatory mechanisms play a major role in determining the observed pattern of AA-NAT gene expression. Remarkably, high levels of AA-NAT transcripts can only be detected in the night pineal; significant levels can also be found in the retina. To characterize the regulatory events that impinge upon the activity of the AA-NAT gene we embarked on the systematic analysis of the AA-NAT promoter. To this end we transfected several AA-NAT promoter derivative constructs to monitor reporter gene activity in both pineal and non-pineal primary cell cultures. Our studies revealed a cooperative arrangement between upstream promoter and downstream intronic regions which appear to contain most of the key elements necessary to ensure the proper spatio-temporal pattern of AA-NAT gene expression.
Assuntos
Arilamina N-Acetiltransferase/genética , Animais , Sequência de Bases , Técnicas de Cultura de Células , Mapeamento Cromossômico , AMP Cíclico/genética , AMP Cíclico/farmacologia , DNA , Inativação Gênica , Íntrons , Dados de Sequência Molecular , Glândula Pineal/citologia , Reação em Cadeia da Polimerase , Regiões Promotoras Genéticas/efeitos dos fármacos , Regiões Promotoras Genéticas/genética , Ratos , Sequências Reguladoras de Ácido Nucleico , Elementos de Resposta/efeitos dos fármacos , Elementos de Resposta/genética , Distribuição Tecidual , TransfecçãoRESUMO
A 10-100-fold rhythm in the activity of arylalkylamine N-acetyltransferase (AA-NAT; EC 2.3.1.87) controls the rhythm in melatonin synthesis in the pineal gland. In some mammals, including the rat, the high nocturnal level of AA-NAT activity is preceded by an approximately 100-fold increase in AA-NAT mRNA. The increase in AA-NAT mRNA is generated by norepinephrine acting through a cAMP mechanism. Indirect evidence has suggested that cAMP enhances AA-NAT gene expression by stimulating phosphorylation of a DNA-binding protein (cAMP-responsive element (CRE)-binding protein) bound to a CRE. The nature of the sites involved in cAMP activation was investigated in this report by analyzing the AA-NAT promoter. An approximately 3700-base pair fragment of the 5'-flanking region of the rat AA-NAT gene was isolated, and the major transcription start points were mapped. The results of deletion analysis and site-directed mutagenesis indicate that cAMP activation requires a CRE.CCAAT complex consisting of a near-perfect CRE and an inverted CCAAT box located within two helical turns.
Assuntos
Arilamina N-Acetiltransferase/genética , AMP Cíclico/genética , Regulação Enzimológica da Expressão Gênica , Regiões Promotoras Genéticas/genética , Animais , Sequência de Bases , Dados de Sequência Molecular , Glândula Pineal/enzimologia , Ratos , Análise de Sequência de DNARESUMO
A remarkably constant feature of vertebrate physiology is a daily rhythm of melatonin in the circulation, which serves as the hormonal signal of the daily light/dark cycle: melatonin levels are always elevated at night. The biochemical basis of this hormonal rhythm is one of the enzymes involved in melatonin synthesis in the pineal gland-the melatonin rhythm-generating enzyme-serotonin N-acetyltransferase (arylalkylamine N-acetyltransferase, AA-NAT, E.C. 2.3.1.87). In all vertebrates, enzyme activity is high at night. This reflects the influences of internal circadian clocks and of light. The dynamics of this enzyme are remarkable. The magnitude of the nocturnal increase in enzyme activity ranges from 7- to 150-fold on a species-to-species basis among vertebrates. In all cases the nocturnal levels of AA-NAT activity decrease very rapidly following exposure to light. A major advance in the study of the molecular basis of these changes was the cloning of cDNA encoding the enzyme. This has resulted in rapid progress in our understanding of the biology and structure of AA-NAT and how it is regulated. Several constant features of this enzyme have become apparent, including structural features, tissue distribution, and a close association of enzyme activity and protein. However, some remarkable differences among species in the molecular mechanisms involved in regulating the enzyme have been discovered. In sheep, AA-NAT mRNA levels show relatively little change over a 24-hour period and changes in AA-NAT activity are primarily regulated at the protein level. In the rat, AA-NAT is also regulated at a protein level; however, in addition, AA-NAT mRNA levels exhibit a 150-fold rhythm, which reflects cyclic AMP-dependent regulation of expression of the AA-NAT gene. In the chicken, cyclic AMP acts primarily at the protein level and a rhythm in AA-NAT mRNA is driven by a noncyclic AMP-dependent mechanism linked to the clock within the pineal gland. Finally, in the trout, AA-NAT mRNA levels show little change and activity is regulated by light acting directly on the pineal gland. The variety of mechanisms that have evolved among vertebrates to achieve the same goal-a rhythm in melatonin-underlines the important role melatonin plays as the hormonal signal of environmental lighting in vertebrates.
Assuntos
Arilamina N-Acetiltransferase/metabolismo , Melatonina/sangue , Glândula Pineal/enzimologia , Sequência de Aminoácidos , Animais , Arilamina N-Acetiltransferase/química , Arilamina N-Acetiltransferase/genética , Sequência de Bases , Evolução Biológica , Humanos , Dados de Sequência Molecular , RNA Mensageiro/metabolismo , Especificidade da EspécieRESUMO
In vertebrates, the circadian rhythm in the activity of serotonin N-acetyltransferase [arylalkylamine N-acetyltransferase (AA-NAT); EC 2.3.1.87] drives the daily rhythm in circulating melatonin. We have discovered that expression of the AA-NAT gene in the rat pineal gland is essentially turned off during the day and turned on at night, resulting in a more than 150-fold rhythm. Expression is regulated by a photoneural system that acts through an adrenergic-cAMP mechanism in pinealocytes, probably involving cAMP response element-binding protein phosphorylation. Turning off AA-NAT expression appears to involve de novo synthesis of a protein that attenuates transcription. A approximately 10-fold night/day rhythm in AA-NAT messenger RNA occurs in the retina, and AA-NAT messenger RNA is also detected at low levels in the brain.
Assuntos
Arilamina N-Acetiltransferase/biossíntese , Encéfalo/enzimologia , Ritmo Circadiano , Melatonina/biossíntese , Glândula Pineal/enzimologia , Transcrição Gênica , Agonistas Adrenérgicos beta/farmacologia , Antagonistas Adrenérgicos beta/farmacologia , Sequência de Aminoácidos , Animais , Arilamina N-Acetiltransferase/química , Sequência Consenso , DNA Complementar , Escuridão , Luz , Masculino , Dados de Sequência Molecular , Especificidade de Órgãos , Fenilefrina/farmacologia , Glândula Pineal/fisiologia , Reação em Cadeia da Polimerase , Propranolol/farmacologia , RNA Mensageiro/análise , RNA Mensageiro/biossíntese , Ratos , Ratos Sprague-Dawley , Receptores Adrenérgicos beta/fisiologia , Homologia de Sequência de Aminoácidos , OvinosRESUMO
Heat and other environmental insults (stress) cause unfolding of proteins, triggering the activation of heat shock transcription factor HSF (HSF1 in vertebrates) that, in higher eukaryotes, involves trimerization of the factor and acquisition of heat shock element (HSE) DNA-binding ability. Interaction of activated HSF1 with HSEs in promoters of genes encoding heat shock proteins (Hsps) enhances their expression. It was suggested that Hsp70 may function as the negative regulator of HSF1. In the simplest model, stress-unfolded proteins would compete with monomeric HSF1 for Hsp70 binding. This competition would result in dissociation of an HSF1-Hsp70 complex, allowing trimerization of released HSF1 monomers. In support of this model, we present evidence herein that 1) non-activated HSF1 forms a 1:1 complex with Hsp70, 2) both rates of heat-induced appearance of HSF1 oligomers and rates of disappearance of HSF1 heterodimers and monomers decrease when concentrations of unengaged Hsps are increased, and 3) transient overexpression of Hsp70 inhibits heat activation of HSF1.
Assuntos
Proteínas de Ligação a DNA/fisiologia , Proteínas de Choque Térmico HSP70/fisiologia , Resposta ao Choque Térmico/fisiologia , Fatores de Transcrição/fisiologia , Animais , Ligação Competitiva , Proteínas de Ligação a DNA/metabolismo , Expressão Gênica , Proteínas de Choque Térmico HSC70 , Proteínas de Choque Térmico HSP70/metabolismo , Proteínas de Choque Térmico HSP72 , Células HeLa , Fatores de Transcrição de Choque Térmico , Proteínas de Choque Térmico , Humanos , Fatores de Transcrição/metabolismoRESUMO
The nuclear orphan receptor RZRbeta is highly expressed in the rat pineal gland. Recent studies proposed that melatonin, the pineal hormone which regulates a wide variety of circadian-linked phenomena, may be the natural ligand of this receptor. These provocative reports prompted us to learn more about RZRbeta and how it might function in circadian physiology. Here we confirm high expression of this receptor in the pineal gland, and report that pineal RZRbeta expression exhibits a strong daily rhythm. Expression is under photoneural regulation and involves an adrenergic --> cAMP mechanism.
Assuntos
AMP Cíclico/metabolismo , Expressão Gênica/fisiologia , Glândula Pineal/metabolismo , Receptores de Superfície Celular/biossíntese , Animais , Sequência de Bases , Bucladesina/farmacologia , Núcleo Celular/metabolismo , Toxina da Cólera/farmacologia , Colforsina/farmacologia , Primers do DNA , Dibutiril GMP Cíclico/farmacologia , Expressão Gênica/efeitos dos fármacos , Cinética , Masculino , Dados de Sequência Molecular , Norepinefrina/farmacologia , Técnicas de Cultura de Órgãos , Glândula Pineal/efeitos dos fármacos , Reação em Cadeia da Polimerase , RNA Mensageiro/análise , RNA Mensageiro/biossíntese , Ratos , Ratos Sprague-Dawley , Receptores de Melatonina , Fatores de Tempo , Peptídeo Intestinal Vasoativo/farmacologiaRESUMO
Pineal serotonin N-acetyltransferase (arylalkylamine N-acetyltransferase, or AA-NAT) generates the large circadian rhythm in melatonin, the hormone that coordinates daily and seasonal physiology in some mammals. Complementary DNA encoding ovine AA-NAT was cloned. The abundance of AA-NAT messenger RNA (mRNA) during the day was high in the ovine pineal gland and somewhat lower in retina. AA-NAT mRNA was found unexpectedly in the pituitary gland and in some brain regions. The night-to-day ratio of ovine pineal AA-NAT mRNA is less than 2. In contrast, the ratio exceeds 150 in rats. AA-NAT represents a family within a large superfamily of acetyltransferases.
Assuntos
Arilamina N-Acetiltransferase/genética , Clonagem Molecular , Glândula Pineal/enzimologia , Sequência de Aminoácidos , Animais , Arilamina N-Acetiltransferase/metabolismo , Encéfalo/metabolismo , Linhagem Celular , Ritmo Circadiano , DNA Complementar/genética , Dados de Sequência Molecular , Glândula Pineal/metabolismo , Hipófise/metabolismo , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Ratos , Retina/metabolismo , Alinhamento de Sequência , Ovinos , TransfecçãoRESUMO
Physiological changes in Fos-like immunoreactivity in the rat pineal gland are shown here to be due primarily to changes in a 42/46-kDa Fos-related antigen (Fra). Studies are presented that indicate this 42/46-kDa Fra is Fra-2, a poorly understood member of the Fos family of transcription factors. Both Fra-2 mRNA and protein are absent during the day and increase robustly at night on a circadian basis; organ culture studies indicate that regulation is mediated by an adrenergic-->cyclic AMP mechanism. AP-1 binding activity changes in parallel to changes in the level of Fra-2 protein.